MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.esmorw.2025.100678

Медицинская библиотека · ESMO real world data and digital oncology · 2026

Histotype-specific incidence and survival of urothelial carcinoma-an analysis of the German North Rhine-Westphalia Cancer Registry.

Darr C, Möller L, Szentkiralyi A, Claassen K, Schürger N, Reis H, Hilser T, Stang A, Hadaschik B A, Kajüter H, Grünwald V

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The aim of this study was to evaluate the incidence and survival of urothelial carcinoma (UC) and non-urothelial tumor types. The primary objective was to define the incidence and survival of pure UC and non-UC tumor types.

MATERIALS AND

METHODS

Malignant invasive urinary cancers of the urothelial tract diagnosed between 2008 and 2022 were identified via the North Rhine-Westphalia Cancer Registry and classified according to the 2016 World Health Organization (WHO) classification (fourth edition). Evaluation focused on pure tumor types: UC, papillary invasive UC (PIUC), squamous-cell carcinoma (SCC), adenocarcinoma (ADC), rarer tumor types and mixed histologies grouped under other specific tumor types (OSTT), and unspecified tumor types (UTT). The primary outcomes were age-standardized incidence rate with estimated annual percentage changes, and relative survival.

RESULTS

UC and PIUC were the most common histology types, accounting for 57.9% and 26.2% (n = 73 751), respectively. The age-standardized incidence of PIUC and UTT decreased over time in both sexes, while OSTT incidence increased over time. Incidence rate declined among men with SCC and among women with ADC. Relative survival was notably poor for SCC (32.3%) and OSTT (23.8%), in contrast to a more favorable outcome for PIUC (72.0%). Decreasing survival with advancing T-stages was noted, particularly for UC, PIUC, ADC, and UTT; T1 in PIUC showed the best survival (81.0%) and T3-4 in OSTT had the poorest survival (16.4%).

CONCLUSION

Relative survival was most favorable for PIUC, UC, and ADC. In contrast, SSC and OSTT exhibited poorer survival outcomes, highlighting a pressing medical need for enhanced treatment options for these subgroups.

Для цитирования: Darr C, Möller L, Szentkiralyi A, Claassen K, Schürger N, Reis H, Hilser T, Stang A, Hadaschik B A, Kajüter H, Grünwald V. Histotype-specific incidence and survival of urothelial carcinoma-an analysis of the German North Rhine-Westphalia Cancer Registry.. ESMO real world data and digital oncology. 2026. DOI: 10.1016/j.esmorw.2025.100678.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.